Health Services, Telemedicine 23andMe to buy online pharmacy Lemonaid for $400M By Elise Reuter - Medcity News
Startups, Startups, Diagnostics 23andMe closes out 2020 with $82.5M in funding By Elise Reuter - Medcity News
Diagnostics, Health Tech Faced with slowing demand, 23andMe cuts 100 employees By Elise Reuter - Medcity News
Startups, Diagnostics Helix and PerkinElmer launch GenePrism genetic risk product in competition with 23andMe By Kevin Truong
Startups, Diagnostics 23andMe launches new diabetes risk test, but experts are wary of its benefit By Kevin Truong
BioPharma, Startups, Patient Engagement 23andMe gets FDA nod for new Colorectal cancer indication test By Kevin Truong
Diagnostics, Pharma FDA approves 23andMe pharmacogenetics test for 33 drug metabolism-related genetic variants By Alaric DeArment
MedCity News eNewsletter Building a company from scratch: 23andMe, athenahealth and Evolent Health CEOs on entrepreneurship By Erin Dietsche
Diagnostics FDA gives nod to 23andMe for no-prescription breast cancer gene testing By Emily Willingham
Diagnostics A 23andMe study of genomics and weight loss seeks pathway to personalized plans to peel pounds By Stephanie Baum
Diagnostics FDA allows 23andMe to reintroduce 10 genetic health risk reports for Parkinson’s, Alzheimer’s, and more By Juliet Preston
